Future Growth Opportunities in the China Point of Care Molecular Diagnostics Market
The China Point of Care Molecular Diagnostics Market is on the cusp of transformative growth, projected to reach USD 1,124.1 million by 2035, with a robust compound annual growth rate (CAGR) of 8.28%. This rapid expansion is fueled by increasing healthcare investments and innovations in diagnostic technologies, enabling faster and more accurate testing solutions. The sharp rise in the China...
0 Comments 0 Shares 40 Views 0 Reviews